Who owns RENEO PHARMACEUTICALS INC?
- Ticker: RPHM
- CUSIP Number: 75974e103
Tip: Access positions for across all investors
Analyze quarterly positions in Reneo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Reneo Pharmaceuticals stock
Who bought or sold RENEO PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 4.8M | $7.7M | 0% | Dec 2023 |
|
| Tang Capital Management | 3.3M | $5.3M | 100% | Dec 2023 |
|
| Carlyle | 2.7M | $4.3M | 0% | Dec 2023 |
|
| RiverVest Venture Management | 2.5M | $4.1M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 2.3M | $3.6M | -1% | Dec 2023 |
|
| Ikarian Capital | 1.9M | $3.1M | 100% | Dec 2023 |
|
| BML Capital Management | 1.3M | $2.1M | 100% | Dec 2023 |
|
| Highbridge Capital Management | 1.1M | $1.8B | 100% | Dec 2023 |
|
| Vanguard Group | 979k | $1.6M | 0% | Dec 2023 |
|
| Aisling Capital Management | 886k | $1.4M | 0% | Dec 2023 |
|
| Caption Management | 410k | $656k | 100% | Dec 2023 |
|
| Two Sigma Investments | 183k | $292k | 100% | Dec 2023 |
|
| Millennium Management | 159k | $254k | 30% | Dec 2023 |
|
| LMR Partners | 120k | $192k | 100% | Dec 2023 |
|
| GSA Capital Partners | 95k | $152k | 100% | Dec 2023 |
|
| Hrt Financial | 87k | $139k | 100% | Dec 2023 |
|
| Citadel Advisors | 82k | $132k | 431% | Dec 2023 |
|
| Jane Street | 79k | $126k | 100% | Dec 2023 |
|
| J. Goldman & Co | 68k | $108k | -57% | Dec 2023 |
|
| Goldman Sachs Group | 65k | $104k | 53% | Dec 2023 |
|
| Bank of New York Mellon | 44k | $70k | 22% | Dec 2023 |
|
| ADAR1 Capital Management | 40k | $64k | 100% | Dec 2023 |
|
| Fifth Lane Capital | 40k | $64k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 38k | $60k | 0% | Dec 2023 |
|
| Jump Financial | 25k | $41k | 100% | Dec 2023 |
|
| Barclays | 24k | $38k | -69% | Dec 2023 |
|
| Bank of America Corporation | 24k | $38k | -42% | Dec 2023 |
|
| ALPS Advisors | 23k | $37k | 100% | Dec 2023 |
|
| SG Americas Securities | 22k | $35k | 100% | Dec 2023 |
|
| Prospera Financial Services | 21k | $33k | 100% | Dec 2023 |
|
| CSS | 20k | $33k | 100% | Dec 2023 |
|
| Commonwealth Equity Services | 19k | $31k | 0% | Dec 2023 |
|
| UBS Group | 16k | $26k | -43% | Dec 2023 |
|
| Jpmorgan Chase & Co | 16k | $26k | 89% | Dec 2023 |
|
| Point72 Middle East FZE | 14k | $22k | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 13k | $21k | -73% | Dec 2023 |
|
| Dynamic Technology Lab Private | 13k | $20k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 11k | $17k | -7% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 10k | $16k | 100% | Dec 2023 |
|
| American International | 6.5k | $10k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 4.8k | $7.7k | 5% | Dec 2023 |
|
| Torno Capital | 4.2k | $6.7k | 100% | Dec 2023 |
|
| China Universal Asset Management | 3.9k | $6.0k | 100% | Dec 2023 |
|
| Citigroup | 2.8k | $4.5k | 427% | Dec 2023 |
|
| Royal Bank of Canada | 2.8k | $4.0k | 40% | Dec 2023 |
|
| Legal & General Group | 1.4k | $2.3k | 24% | Dec 2023 |
|
| Amalgamated Bank | 1.2k | $2.0k | -8% | Dec 2023 |
|
| Cubist Systematic Strategies | 963.00 | $1.5k | 100% | Dec 2023 |
|
| Summit Investment Advisors | 799.00 | $1.3k | 0% | Dec 2023 |
|
| Federated Investors | 647.00 | $1.0k | -99% | Dec 2023 |
|
| New York State Common Retirement Fund | 221.00 | $0 | -7% | Dec 2023 |
|
| Advisor Group Holdings | 41.00 | $66.001800 | -59% | Dec 2023 |
|
Who sold out of Reneo Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Eventide Asset Management | Sep 2023 | 2.1M | $16M |
| Franklin Resources | Sep 2023 | 1.5M | $11M |
| Dr. Jeffrey R. Jay, M.D. | Sep 2023 | 1.2M | $8.9M |
| First Light Asset Management | Sep 2023 | 272k | $2.1M |
| MAI Wealth Advisors | Sep 2023 | 124k | $942k |
| Trexquant Investment | Sep 2023 | 21k | $158k |
| Global Retirement Partners | Sep 2023 | 100.00 | $735.000000 |